radcliffeCARDIO Profile Banner
Radcliffe Cardiology Profile
Radcliffe Cardiology

@radcliffeCARDIO

Followers
23K
Following
10K
Media
10K
Statuses
25K

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide.

Joined May 2009
Don't wanna be here? Send us removal request.
@radcliffeCARDIO
Radcliffe Cardiology
18 minutes
๐Ÿ“š New #JAPSCJournal Article: "PAN Technique Basics: How and Who" ๐Ÿ“š Just Published! ๐Ÿ”“Access it here ๐Ÿ‘‰ https://t.co/lAI7T1m1Ag @apsc_office #CVImaging #MedEd
0
0
0
@radcliffeCARDIO
Radcliffe Cardiology
18 hours
๐ŸŽ“ โœจ Rhythm Interventions Online is now CME-accredited! Register here to earn up to 14 credits on day one and two ๐Ÿ‘‰ https://t.co/EoWtz9cX3W *Rhythm Interventions Online 2025โ€™s Global Programme has been accredited by the European Board for Accreditation of Continuing
0
1
1
@radcliffeCARDIO
Radcliffe Cardiology
18 hours
๐Ÿ“ข Save the date! โœจJoin New Horizons in Dyslipidaemia on 12 Feb 2026. ๐Ÿ”—Register now ๐Ÿ‘‰ https://t.co/RbetTMG5gk ๐ŸฉบJoin leading global experts for a cutting-edge #CME event dedicated to the future of lipid management and cardiovascular risk reduction. #Cardiology #CardioEd
0
0
0
@radcliffeCARDIO
Radcliffe Cardiology
20 hours
Can a left ventricular ejection fraction (LVEF)-centric definition truly capture the dynamic nature of heart failure (HF)? Prof Giuseppe Rosano, Dr John Teerlink and Prof Koichiro Kinugawa explore the limitations of the LVEF-centric definition, its impact on trial recruitment
0
0
0
@radcliffeCARDIO
Radcliffe Cardiology
23 hours
๐Ÿ“š Latest News : "Routine CCTA After Left Main PCI Fails Primary Endpoint" ๐Ÿ”“Access it here ๐Ÿ‘‰ https://t.co/uwFgXycbiF
0
0
1
@radcliffeCARDIO
Radcliffe Cardiology
23 hours
๐Ÿ“š Latest News : "Genetic Link to CVD in Hypertensive Pregnancy" ๐Ÿ“š New genetic evidence suggests that hypertensive disorders during pregnancy causally increase the risk of cardiovascular disease later in life. ๐Ÿ‘‰ https://t.co/kgwrWGKxED
0
0
1
@radcliffeCARDIO
Radcliffe Cardiology
23 hours
Discover how aldosterone dysregulation contributes to vascular and renal damage. Join Dr Sophia Ambruso and Prof Paolo Mulatero for expert insights into the pathological consequences of aldosterone dysregulation and its role in target organ damage. Watch now ๐Ÿ‘‰
0
0
1
@radcliffeCARDIO
Radcliffe Cardiology
1 day
๐Ÿ“š New #JAPSCJournal Article: "PAN Procedure for ASD, PFO and TEER" ๐Ÿ“š Just Published! ๐Ÿ”“Access it here ๐Ÿ‘‰ https://t.co/zbL4OZQDV5 @apsc_office #CVImaging #MedEd
0
0
1
@radcliffeCARDIO
Radcliffe Cardiology
1 day
From sex-specific cardiac anatomy to the role of validated home blood pressure and pulse devices, this #ESC2025 interview series provides clinicians with actionable insights to detect cardiovascular diseases earlier and improve outcomes. ๐ŸŽฅ https://t.co/WZwM0jkrkV Recorded
0
0
0
@radcliffeCARDIO
Radcliffe Cardiology
1 day
๐Ÿšจ The next #CardioOnc webinar is TODAY at 14:00 GMT | 09:00 EST ๐Ÿ”— https://t.co/LUDdOj4LOo Join this weekโ€™s discussion led by Dr Joe Carver and a panel of experts for an in-depth discussion on the implementation of whole person cancer care through the lens of cardio-oncology.
0
5
2
@radcliffeCARDIO
Radcliffe Cardiology
2 days
๐ŸŽ™๏ธNEW #AHA25 #LBCT Interview ๐ŸŒŸ Dr @VivekReddyMD shares findings from the PFA-SHAM study. ๐Ÿ“ฝ๏ธWatch here๐Ÿ‘‰ https://t.co/NWhvPwqkNc ๐Ÿ“ŠAfter 6 months, #PFA was superior to sham #ablation with regard to the primary endpoint of freedom from #AFib recurrence. #AHA2025 #CardioEd
0
0
0
@radcliffeCARDIO
Radcliffe Cardiology
2 days
๐Ÿ“Š BRAND-NEW TRIAL DATA from #ESCCongress 2025 revealed important insights into aldosterone synthase inhibitors for uncontrolled hypertension. Dr Ana Maria Cebriรกn Cuenca and Prof Markus Schlaich as they translate late-breaking study findings into actionable clinical strategies.
0
0
1
@radcliffeCARDIO
Radcliffe Cardiology
2 days
Prof Augusto Dโ€™Onofrio reviews long-term data on surgical bioprostheses, highlighting the durability and performance of RESILIA tissue technology in aortic valve replacement. Watch the full 16-minute session on 'The RESILIA Tissue Technology & Surgical Experience' ๐Ÿ”—
0
0
0
@Arrhythmia_A
ArrhythmiaAcademy
2 days
In just one hour, learn how leadless pacing is transforming care in complex cardiac cases. This four-part video series explores the use of leadless pacemakers in TTVR and active CIED infection. Watch to: โ€ข Identify when and why leadless pacing is indicated โ€ข Apply real-world
0
1
6
@radcliffeCARDIO
Radcliffe Cardiology
2 days
๐Ÿ“š New #JAPSCJournal Article: "Advancing a Global Health Agenda for CVD" ๐Ÿ“š Just Published! ๐Ÿ”“Access it here ๐Ÿ‘‰ https://t.co/YCzyr1TznH @apsc_office #MedEd #CardioEd
0
0
2
@radcliffeCARDIO
Radcliffe Cardiology
3 days
Only one day to go until 'Optimizing Valvular Heart Disease Patient Care: Evidence-Based Insights from Multidisciplinary Teams' https://t.co/uQS0iGvXVt Tune in live to explore the value of collaborative heart valve team approaches and updates on the clinical burden of aortic
0
4
3
@radcliffeCARDIO
Radcliffe Cardiology
3 days
Dr Mantas Buitkus shares practical tips and best practices for performing the EKOS procedure in acute pulmonary embolism (PE). Watch the full insights here ๐Ÿ‘‰ https://t.co/22FrqfNrzL He outlines how prompt intervention can reduce mortality from around 30% to less than 10%,
0
0
2
@RIOCongress
Rhythm Interventions Online
3 days
๐Ÿšจ Only eight days until Rhythm Interventions Online 2025!! Now in its sixth year, RIO has firmly established itself as a must-attend global event, providing world-class education to thousands of healthcare professionals worldwide. โœจ Exclusively live. 100% free. Designed for
1
8
19
@radcliffeCARDIO
Radcliffe Cardiology
3 days
Dr Mintu Turakhia highlights how 14-day monitoring captures more arrhythmias beyond the first week, with patient-centered convenience๐Ÿ‘‰ https://t.co/pEukwk7qGW ๐Ÿ“Š In the AMALFI study, despite a mean age of almost 80 and comorbidities like heart failure, stroke, and CKD,
0
2
3
@radcliffeCARDIO
Radcliffe Cardiology
3 days
Small annuli remain one of the biggest challenges in treating severe aortic stenosis, particularly across the APAC region. Learn how to overcome these challenges and improve patient outcomes ๐Ÿ‘‰ https://t.co/3AMxYcGeXk Join leading TAVI experts on 24 November, 14:30 IST | 18:00
0
0
2